News | August 13, 2014

Polypill Strategy May Improve Global Secondary Cardiovascular Prevention

Review shows polypill approach may overcome barriers to compliance, reduce costs

August 13, 2014 — The polypill, a combination pill taken just once a day that includes key medications for secondary prevention of heart disease, may be an effective low-cost strategy to improve adherence to medication recommendations and reduce costs, according to researchers from Spain and New York, who reviewed research on the polypill.

The review article, “A Polypill Strategy to Improve Global Secondary Cardiovascular Prevention,” was published online in the Journal of the American College of Cardiology.

Cardiovascular disease is the leading global cause of death, accounting for 17.3 million deaths per year. As the population ages and patients with heart disease survive longer, a growing pool of patients could benefit from secondary prevention of heart disease.

Secondary prevention includes lifestyle changes and the use of medications — including statins, medications to reduce blood pressure and antithrombotic agents. Use of these medications, which are generally low cost and safe, is thought to be responsible for half of the overall 50 percent reduction in mortality from heart disease in the past 20 years in some Western countries.

According to the study, there is room for improvement in secondary prevention, especially in nations with limited resources. The polypill, a combination pill taken just once a day that includes key medications for secondary prevention, has been proposed as a low-cost strategy to improve adherence and reduce costs.

For more information:

Related Content

CIRS, Dynamic Cardiac Phantom, CT, RSNA 2015

Image courtesy of CIRS Inc.

Technology | Quality Assurance (QA)| November 24, 2015
The Dynamic Cardiac Phantom is a precision instrument which mimics the translation and rotational motion of the heart...
dosimetry phantoms
News | Computed Tomography (CT)| November 23, 2015
CIRS ATOM phantoms are a full line of anthropomorphic, cross sectional ...
PACSHealth, Virtual Phantoms, partner, DoseMonitor, VirtualDose CT, radiation

VirtualDose CT screen capture courtesy of Virtual Phantoms Inc.

News | Radiation Dose Management| July 13, 2015
PHS Technologies Group LLC, a division of PACSHealth LLC, announced that it will integrate VirtualDose CT (computed...

Model 711-HN photo courtesy of CIRS

News | November 18, 2014
CIRS will feature a variety of quality assurance (QA), research and training phantoms for all radiology imaging...
The Nugget

Images Courtesy of Radcal

Technology | November 18, 2014
Radcal Corporation announced the release of its first WiFi device, the Nugget, which will be unveiled at the 2014 RSNA...
Technology | November 07, 2014
Solid Water HE is the next generation of solid water phantoms by Gammex. It is designed for both therapy and imaging...
Gammex 464, CT phantom, CT systems, scanner, torso
Technology | November 03, 2014
The Gammex 464 ...
McKesson QICS Cardiac PACS QA Systems Cardiology Data Management
Technology | March 12, 2014
McKesson announced a cardiology solution called Qualitative Intelligence and Communication System (QICS). QICS for...
News | February 10, 2014
Fluke Biomedical, a manufacturer of biomedical test instruments, acquired Unfors RaySafe. Unfors RaySafe produces ...
Technology | November 20, 2012
The environment surrounding a medical imaging system can now be monitored with Toshiba America Medical Systems Inc.’s e...
Overlay Init